New Research Poster Presentation 3.38: Effect of Cognitive Ability on Aripiprazole Treatment of Irritability Associated with Autistic Disorder

Thursday, October 29, 2009 12:30 PM

Raymond Mankoski, M.D., Ph.D., Bristol-Myers Squibb Company, Plainsboro, NJ

George Manos, Ph.D., Bristol-Myers Squibb Company, Wallingford, CT

Jessie Chambers, Ph.D., Bristol-Myers Squibb, Plainsboro, NJ

Suja Mathew, B.S., Otsuka America Pharmaceutical, Inc., Rockville, MD

Andrei Pikalov, M.D., Ph.D., Otsuka America Pharmaceutical, Inc., Rockville, MD

Lisa Kamen, M.H.A., Bristol-Myers Squibb Company, Plainsboro, NJ

Ronald Marcus, M.D., Bristol-Myers Squibb Company, Wallingford, CT

Randall Owen, M.D., Bristol-Myers Squibb Comopany, Wallingford, CT

		56th Annual Meeting Tentative Program Schedule
		Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 3.38 Effect of Cognitive Ability on Aripiprazole Treatment of Irritability Associated with Autistic Disorder